Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 HKD | +0.56% |
|
-1.10% | -29.80% |
06-21 | Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial | MT |
06-21 | Shanghai Fudan Zhangjiang Bio-Pharmaceutical Terminates Libod Marketing Agreement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.80% | 701M | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
-22.81% | 4.4B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 1349 Stock
- News Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
- Shanghai Fudan-Zhangjiang Admits First Patient in Confirmatory Clinical Trial for Tumor Margin Visualization